Non-invasive surfactant aerosol therapy for RDS
Ended Project Grant Awarded Last action
- Award ID
- R43HL142335
- Recipient
-
Kaer Biotherapeutics UEI J6MVM8F3HM25
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,719
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- California, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $299,719 |
Quick answers
Who received award R43HL142335?
R43HL142335 was awarded to Kaer Biotherapeutics by National Heart Lung and Blood Institute (National Institutes of Health) on February 15, 2019.
How much is award R43HL142335 worth?
$299,719 has been obligated on R43HL142335.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award